JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
JXN
Jackson Financial Inc.
JXN has a slight edge over JPM overall, supported by stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
JXN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
JXN's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like JXN.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over JXN in the historical PE scenario, which offers more potential upside but is not a forecast.
JXN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1x | $12.52 | -91% |
| Fair | 4x | $48.54 | -65% |
| Forward | 4.4x | $139 | — |
| Current | 11x | $139 | — |
| Expensive | 65x | $792 | +471% |
Historical ranges are pointers, not guarantees.
JXN's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 4.4x next year's earnings, in its fair range.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
JXN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
JXN has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over JXN on earnings, with more consistent year-over-year improvement.
JXN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $31.37 | +156% |
| Q3 2026 | $12.27 | +63% |
| Q2 2026 | $0.82 | +257% |
| Q1 2026 | -$6.00 | -555% |
| Q4 2025 | -$0.24 | -102% |
| Q3 2025 | $7.52 | +$19.21 |
| Q2 2025 | $0.23 | -99% |
| Q1 2025 | $1.32 | -97% |
| Q4 2024 | $11.74 | +9.1% |
JXN's earnings per share have fallen from their peak: $12.27 over the past year, against $78.10 in late 2022.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over JXN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
JXN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +8.9% |
| Q1 2026 | $2.9B | -23% |
| Q4 2025 | $2B | +784% |
| Q3 2025 | $1.4B | -33% |
| Q4 2024 | $225M | -75% |
| Q3 2024 | $2.1B | -19% |
| Q2 2024 | $1.2B | +204% |
| Q3 2023 | $2.6B | -35% |
JXN's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 54% | +4.3 points |
| Q2 2026 | -309% | N/A |
| Q1 2026 | 75% | -7.3 points |
| Q4 2025 | 64% | +284 points |
| Q3 2025 | 50% | -15 points |
| Q1 2025 | 82% | N/A |
| Q4 2024 | -220% | -243 points |
| Q3 2024 | 65% | -11 points |
JXN has the edge over JPM on profitability, with a higher operating margin.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
JXN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +3.4% |
| Q2 2026 | $1.8B | +58% |
| Q1 2026 | $1B | -34% |
| Q4 2025 | $1.6B | +6.3% |
| Q3 2025 | $1.4B | +0.4% |
| Q2 2025 | $1.2B | -21% |
| Q1 2025 | $1.6B | +12% |
| Q4 2024 | $1.5B | -6.7% |
JXN has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over JXN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
JXN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.6% | -1.8M shares |
| 1 year | -2.6% | -1.8M shares |
| 3 years | -17% | -14.4M shares |
| 5 years | -28% | -26M shares |
| Available history | -28% | -26M shares |
JXN has 68M diluted shares, down 2.6% from a year ago, with $839M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $233M |
| Q2 2026 | $227M |
| Q1 2026 | $227M |
| Q4 2025 | $152M |
| Q3 2025 | $157M |
| Q2 2025 | $158M |
| Q1 2025 | $202M |
| Q4 2024 | $99M |
JXN spent $839M buying back its own shares over the past year, up 36% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
JXN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2023 | 0.4x | Very low |
| Q4 2022 | 0.0x | Very low |
| Q3 2022 | -0.2x | Net Cash |
| Q2 2022 | -0.2x | Net Cash |
JXN's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JXN.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
JXN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.3 | Neutral |
| Stochastic | 53.7 | Neutral |
JXN's weekly RSI is 63 (neutral) and its Stochastic is 54 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
JXN PE vs Financial Services Sector
| Metric | JXN | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 70 | 65 | 5 pts above |
JXN has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
JXN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $132.6 | 4.6% above |
| 20 week MA | $129.5 | 7.1% above |
| 50 week MA | $117.3 | 18% above |
| 100 week MA | $103.3 | 34% above |
| 200 week MA | $80.4 | 72% above |
JXN has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
JXN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $28.8 | $39.9 | +39% |
| 2022 | $39.9 | $35.0 | -12% |
| 2023 | $35.0 | $51.2 | +46% |
| 2024 | $51.2 | $88.0 | +72% |
| 2025 | $88.0 | $108.2 | +23% |
| 2026 YTD | $108.2 | $138.6 | +28% |
JXN has the edge over JPM on returns for 2026, with the stronger performance.